Prospective Monitoring of in Vivo Biological Effects of Natalizumab (Avla-4, Tysabri®) in Patients with Ms

Autor: Bar-Or, Amit, Niino, Masaaki, Simard, Marie-Lune, Bodner, Caroline, Alatab, Sudabeh, Fournier, Alyson, Gano, Dawn, Jin Kim, Ho
Zdroj: In Clinical Immunology 2006 119 Supplement:S48-S48
Databáze: ScienceDirect